蒸汽密度
9.7 (vs air)
蒸汽压
1 mmHg ( 107 °C)
方案
≥98.0% (GC)
表单
liquid
环保替代产品特性
Less Hazardous Chemical Syntheses
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
折射率
n20/D 1.442 (lit.)
沸点
235 °C/150 mmHg (lit.)
密度
1.14 g/mL at 25 °C (lit.)
官能团
ester
hydroxyl
环保替代产品分类
, Aligned
SMILES字符串
CCOC(=O)CC(O)(CC(=O)OCC)C(=O)OCC
InChI
1S/C12H20O7/c1-4-17-9(13)7-12(16,11(15)19-6-3)8-10(14)18-5-2/h16H,4-8H2,1-3H3
InChI key
DOOTYTYQINUNNV-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
相关类别
一般描述
我们致力于为您提供更环保的替代产品,以符合“绿色化学的 12 项原则”的一项或多项原则要求。该产品可在膜制备中替代剧毒稀释剂,符合“减少有害化学合成”的要求。 点击此处了解更多信息。
柠檬酸三乙酯是一种安全的直接食品添加剂。
应用
在对使用近红外(NIR)光谱法测定增塑剂含量和烧结温度对碾压制备型缓释骨架片断裂力的影响进行可行性分析时,柠檬酸三乙酯被用作增塑剂。
储存分类代码
10 - Combustible liquids
WGK
WGK 1
闪点(°F)
311.0 °F - closed cup
闪点(°C)
155 °C - closed cup
个人防护装备
Eyeshields, Gloves
Monice M Fiume et al.
International journal of toxicology, 33(2 suppl), 16S-46S (2014-05-28)
The CIR Expert Panel (Panel) assessed the safety of citric acid, 12 inorganic citrate salts, and 20 alkyl citrate esters as used in cosmetics, concluding that these ingredients are safe in the present practices of use and concentration. Citric acid
Vivek S Dave et al.
Drug development and industrial pharmacy, 41(6), 898-905 (2014-05-03)
The aim of this study was to investigate the feasibility of near-infrared (NIR) spectroscopy for the determination of the influence of sintering temperature and plasticizer levels on the breaking force of extended-release matrix tablets prepared via roller-compaction. Six formulations using
T Quinten et al.
AAPS PharmSciTech, 13(4), 1197-1211 (2012-09-12)
Sustained-release matrix tablets based on Eudragit RL and RS were manufactured by injection moulding. The influence of process temperature; matrix composition; drug load, plasticizer level; and salt form of metoprolol: tartrate (MPT), fumarate (MPF) and succinate (MPS) on ease of
Fang Liu et al.
Journal of controlled release : official journal of the Controlled Release Society, 133(2), 119-124 (2008-10-22)
A novel double-coating enteric system was developed to accelerate drug release in conditions resembling the upper small intestine. The system comprises an inner coat (partially neutralised EUDRAGIT L 30 D-55 and organic acid) and an outer coat (standard EUDRAGIT L
Lisa Claire du Toit et al.
Journal of pharmaceutical sciences, 97(6), 2176-2207 (2007-09-21)
The crux of this research was the pragmatic investigation into the formulation of a reconstitutable multiparticulate anti-tuberculosis drug delivery system for facilitated administration for the attainment of segregated gastrointestinal (GI) delivery of rifampicin (RIF) and isoniazid (INH) in order to
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持